Dec 5, 2024 | Future Proof Your Lab: Streamline Variant Interpretation with Automation

Mark has extensive experience in genome sequencing and clinical data analysis underlying the vision and technology driving the Genomenon suite of software tools.

Data-driven product manager with expertise in clinical genomics, global team building, and driving customer-focused products forward through market analysis and cross-functional collaboration.

Amy Gaviglio is a genetic counselor and founder of Connetics Consulting, LLC which provides newborn screening, genomics, and rare disease services globally. She has worked in the NBS and rare disease space for the past 17 years. Amy currently works with the Centers for Disease Control and Prevention, the Association of Public Health Laboratories (APHL), Expecting Health, RTI International, and several other rare disease and genomics organizations. She is co-chair of APHL’s New Disorders in Newborn Screening Subcommittee and is a member of additional national groups including the Rare Disease Diversity Coalition and EveryLife Foundation’s Community Congress. She also serves on the Executive Board for the International Society of Neonatal Screening and is a member of the MPS Society’s Scientific Advisory Board. Finally, Amy serves as Chair of the NBS Expert Panel for the Clinical and Laboratory Standards Institute.

‍